longbridge
  • Explore
    Products
    Private Wealth ManagementUS StocksSG StocksHK StocksUS OptionsUS Pre-Market OptionsETFsREITsWarrantsCash Plus
    Tools
    Longbridge SkillLongbridge AILongbridge APIPaper TradingDividend HubLongbridge Pro
  • Café
longbridge

ALPHAMAB-B

09966

5.1902.54% ( -0.135 )
Delay Trading: Nov 19, 11:45:50
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile

News

  • Alphamab hits 52-week low

    Market Movers·Nov 19, 2026 at 01:31 AM
    09966-2.07%
  • Alphamab Oncology Discloses Share Repurchase in HKEX Next Day Return

    PUBT·Nov 16, 2026 at 01:59 PM
    09966-2.07%
  • 康宁杰瑞制药-B 创 52 周新低,现报 $5.54,现跌约 3%。

    Market Movers·Nov 16, 2026 at 01:33 AM
    09966-2.07%
  • Alphamab falls 6% in Hong Kong trading

    Market Movers·Nov 12, 2026 at 06:25 AM
    09966-2.07%
  • Alphamab Oncology Appoints David Ng as Chief Financial Officer

    PUBT·Nov 12, 2026 at 12:02 AM
    09966-2.07%
  • Alphamab Oncology Files Next Day Disclosure Return With HKEX Announcing Share Buyback

    PUBT·Nov 11, 2026 at 10:52 AM
    09966-2.07%
  • Alphamab Oncology files next-day disclosure with HKEX announcing share buyback

    PUBT·Nov 6, 2026 at 12:27 PM
    02576+1.61%09966-2.07%
  • Alphamab Oncology Reports Share Buyback in HKEX Next Day Disclosure Return

    PUBT·Nov 5, 2026 at 11:19 AM
    09966-2.07%
  • Alphamab climbs 7% as FDA clears JSKN021 for clinical trials

    Market Movers·Nov 4, 2026 at 01:38 AM
    09966-2.07%
  • Alphamab Oncology Discloses Share Buyback in HKEX Next Day Return

    PUBT·Nov 3, 2026 at 12:48 PM
    09966-2.07%
  • Alphamab Oncology Gets FDA Approval for JSKN021 Phase I Trial

    PUBT·Nov 2, 2026 at 04:01 AM
    09966-2.07%
LongbridgeAI
© 2026 Longbridge|Terms of ServicePrivacy Policy